Pidilite’s consolidated net profit up by more than 30% in June quarter

Pidilite Industries saw profits rise over thirty percent year-on-year. Revenue from operations increased by more than twenty-one percent during the quarter. Earnings before interest, tax, depreciation, and amortisation also jumped significantly. Sales volume grew by more than eleven percent, aiding the company’s performance. The company implemented price hikes across categories to manage rising input costs.

IPA seeks to regularise ‘legacy’ drugs

The Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examples include sodium valproate and carbamazepine tablets. Regulatory gaps have persisted for over a decade. This situation requires urgent attention from drug authorities.